1023
|
Actacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Subunit
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
1024
|
Quinvaxem inj.
|
Diphtheria
|
Corynebacterium diphtheriae
|
Subunit
|
Berna Biotech Korea Corp.
|
Approved
|
Intramuscular
|
22889824
|
NA
|
1053
|
Actacel
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Subunit
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
1054
|
Quinvaxem inj.
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Subunit
|
Berna Biotech Korea Corp.
|
Approved
|
Intramuscular
|
22889824
|
NA
|
1085
|
Actacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Subunit
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
1086
|
Quinvaxem inj.
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Subunit
|
Berna Biotech Korea Corp.
|
Approved
|
Intramuscular
|
22889824
|
NA
|
1135
|
Mencevax ACWY
|
Meningococcal disease
|
Neisseria meningitidis
|
Subunit
|
GlaxoSmithKline Biologicals
|
Approved
|
Subcutaneous
|
NA
|
NA
|
1161
|
Quinvaxem inj.
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Subunit
|
Berna Biotech Korea Corp.
|
Approved
|
Intramuscular
|
22889824
|
NA
|
1164
|
Actacel
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Subunit
|
Sanofi Pasteur Ltd
|
Approved
|
Intramuscular
|
NA
|
NA
|
1169
|
LEP-F1 + GLA-SE
|
Leprosy
|
Mycobacterium leprae
|
Subunit
|
IDRI
|
Clinical - Withdrawn
|
Intramuscular
|
31899025
|
NCT03947437
|
1171
|
Flagellin/F1/V
|
Plague
|
Yersinia pestis
|
Subunit
|
National Institute of Allergy and Infectious Diseases (NIAID)
|
Clinical - Phase 1
|
NA
|
NA
|
NCT01381744
|
1191
|
Invaplex 50
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Subunit
|
U.S. Army Medical Research and Development Command
|
Clinical - Phase 1, Phase 2
|
Intranasal
|
34258576
|
NCT00485134
|
1208
|
ACE393
|
Campylobacteriosis
|
Campylobacter genus
|
Subunit
|
TD Vaccines A/S
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00859716
|
1228
|
J5-OMP vaccine
|
Bacterial Sepsis
|
E.coli, group B Streptococcus, Neisseria meningitidis, Salmonella, Haemophilus influenzae type b, and Listeria monocytogenes.
|
Subunit
|
National Institute of Allergy and Infectious Diseases (NIAID)
|
Clinical - Terminated
|
Intramuscular
|
20593272
|
NCT01164514
|
1241
|
H56
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Subunit
|
Aeras
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT03512249
|
1349
|
GEN-004
|
Pneumococcal
|
Streptococcus pneumoniae
|
Subunit
|
Genocea Biosciences, Inc.
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT02116998
|